Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Use Study of CP-675,206 for Advanced Melanoma

NCT00584493 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00584493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00584493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Use Study of CP-675,206 for Advanced Melanoma
Lead sponsor
Pfizer
Phase
Expanded access
Overall status
No longer available
Start date
May 31, 2008
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced unresectable melanoma